Dr. Bhatt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
988102 Nebraska Medical Ctr
Omaha, NE 68198Phone+1 402-559-5600Fax+1 402-559-6615
Education & Training
University of Nebraska Medical Center College of MedicineFellowship, Hematology and Medical Oncology, 2012 - 2015
Zucker School of Medicine at Hofstra/Northwell at Staten Island University HospitalResidency, Internal Medicine, 2009 - 2012
Tribhuvan University Inst of MedicineClass of 2009
Certifications & Licensure
IA State Medical License 2021 - 2026
NE State Medical License 2014 - 2026- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Geriatric Assessment & Genetic Profiling to Personalize Therapy in Older Adults With Acute Myeloid Leukemia Start of enrollment: 2017 Jul 07
- Study of Ruxolitinib in Sclerotic Chronic Graft-Versus-Host Disease After Failure of Systemic Glucocorticoids Start of enrollment: 2018 Sep 05
- ONC 201 Maintenance Therapy in Acute Myeloid Leukemia and Myelodysplastic Syndrome After Stem Cell Transplant Start of enrollment: 2019 Jul 30
- Join now to see all
Publications & Presentations
PubMed
- Metabolic syndrome and symptom burden in allogeneic hematopoietic stem cell transplantation survivors.Jonathan Q Trinh, Jonathan D Nilles, Moataz Ellithi, Michael M Haddadin, Lori Maness-Harris
Future Oncology. 2024-11-24 - A Multicenter Phase II Trial of Ruxolitinib for Treatment of Corticosteroid Refractory Sclerotic Chronic Graft-Versus-Host Disease.Vijaya Raj Bhatt, Valerie K Shostrom, Hannah K Choe, Betty K Hamilton, Krishna Gundabolu
Journal of Clinical Oncology. 2024-11-20 - Anti-CLL1 liposome loaded with miR-497-5p and venetoclax as a novel therapeutic strategy in acute myeloid leukemia.Qiaoyu Pan, Xiaofei Xin, Sohan Mahto, Yuxiang Dong, Virender Kumar
Molecular Therapy. 2024-11-06
Abstracts/Posters
- Integrating Geriatric Assessment and Genetic Profiling to Personalize Therapy Selection in Older Adults with Acute Myeloid Leukemia (AML)Vijaya R. Bhatt, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Cognitive Impairment Is Associated with Inferior Survival and Increased Non-Relapse Mortality in Older Allogeneic Hematopoietic Cell Transplant (alloHCT) Recipients: A...Vijaya R. Bhatt, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- Effect of Using Multiagent Versus Single Agent Chemotherapy on Overall Survival (OS) of Older Adults with Acute Myeloid Leukemia (AML)61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Therapy preference scale: A novel questionnaire to understand patients’ preferences of cancer treatment.2019 ASCO Annual Meeting - 6/1/2019
- Impact of Leukapheresis and Time to Chemotherapy on Outcomes of Newly Diagnosed Patients (pts) with Acute Myeloid Leukemia (AML) Presenting with Hyperleukocytosis: An ...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
Distinguished Scientist: Vijaya Bhatt, MBBSFebruary 5th, 2021- ‘Health Care Works Are Exhausted,’ UNMC Letter Receives 2k+ SignaturesNovember 18th, 2020
- UNMC and NE Medicine Trial Will Test if Cancer Drugs Can Remove LeukemiaNovember 16th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
